Question

A 62-year-old with HFrEF (EF 28%), CKD stage 3, and potassium 4.6 mEq/L is on ARNI, beta-blocker, and SGLT2 inhibitor. Next mortality-reducing therapy?

Accepted Answer

Add mineralocorticoid receptor antagonist if no contraindication

Answer

Add thiazide diuretic for mortality

Answer

Start nitrate monotherapy

Answer

Stop ARNI to add hydralazine only

Answer

No further therapy can reduce mortality

Practice question

A 62-year-old with HFrEF (EF 28%), CKD stage 3, and potassium 4.6 mEq/L is on ARNI, beta-blocker, and SGLT2 inhibitor. Next mortality-reducing therapy?